Targeted Drug-Resistance Testing Strategy for Multidrug-Resistant Tuberculosis Detection, Lima, Peru, 2005–2008

Velásquez, Gustavo E.; Yagui, Martin; Cegielski, J. Peter; Asencios, Luis; Bayona, Jaime; Bonilla, Cesar; Jave, Hector O.; Yale, Gloria; Suárez, Carmen; Atwood, Sidney; Contreras, Carmen C.; Shin, Sonya S.

i

Targeted Drug-Resistance Testing Strategy for Multidrug-Resistant Tuberculosis Detection, Lima, Peru, 2005–2008

Supporting Files Public Domain

Mar 2011
By Velásquez, Gustavo E. ; Yagui, Martin ; Cegielski, J. Peter

Details

Alternative Title:

Emerg Infect Dis
Personal Author:

Velásquez, Gustavo E. ; Yagui, Martin ; Cegielski, J. Peter ; Asencios, Luis ; Bayona, Jaime ; Bonilla, Cesar ; Jave, Hector O. ; Yale, Gloria ; Suárez, Carmen ; Atwood, Sidney ; Contreras, Carmen C. ; Shin, Sonya S.
Description:

The Peruvian National Tuberculosis Control Program issued guidelines in 2006 specifying criteria for culture and drug-susceptibility testing (DST), including district-level rapid DST. All patients referred for culture and DST in 2 districts of Lima, Peru, during January 2005-November 2008 were monitored prospectively. Of 1,846 patients, 1,241 (67.2%) had complete DST results for isoniazid and rifampin; 419 (33.8%) patients had multidrug-resistant (MDR) TB at the time of referral. Among patients with new smear-positive TB, household contact and suspected category I failure were associated with MDR TB, compared with concurrent regional surveillance data. Among previously treated patients with smear-positive TB, adult household contact, suspected category II failure, early relapse after category I, and multiple previous TB treatments were associated with MDR TB, compared with concurrent regional surveillance data. The proportion of MDR TB detected by using guidelines was higher than that detected by a concurrent national drug-resistance survey, indicating that the strategy effectively identified patients for DST.
Subjects:
Source:

Emerg Infect Dis. 17(3):432-440.
Document Type:

Journal Article
Volume:

17
Issue:

3
Download URL:

https://stacks.cdc.gov/view/cdc/18496/cdc_18496_DS1.pdf
File Type:

[PDF - 235.05 KB]
Collection(s):

Emerging Infectious Diseases
Main Document Checksum:

urn:sha256:7204c28cc92d0abad426ef11a3adb4c934fadecb4d4b21d467999f8618f57584

10-1553_finalR.nxml

Download txt
license.txt

Download txt

ON THIS PAGE

Details Supporting Files

Was this page helpful?

Found an issue?

Send us an email at:

publishinghd@cdc.gov

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.